Successful simultaneous pancreas kidney transplantation in maturity-onset diabetes of the young type 5

Transplantation

Volumn 92, Issue 8, 2011, Pages

  Halbritter, Jan ^a   Mayer, Christof ^a   Bachmann, Anette ^a   Rasche, Franz M ^a   Uhlmann, Dirk ^a   Stumvoll, Michael ^a   Lindner, Tom H ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CREATINE; HEMOGLOBIN A1C; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ORAL ANTIDIABETIC AGENT; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY; TRIACYLGLYCEROL LIPASE;

ADULT; CASE REPORT; CREATININE BLOOD LEVEL; DIABETES MELLITUS; GENE; GLYCEMIC CONTROL; GRAFT REJECTION; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HNF 1BETA GENE; HUMAN; HYPOTROPHY; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEFICIENCY; INSULIN RELEASE; INTRAVENOUS GLUCOSE TOLERANCE TEST; KIDNEY CYSTIC HYPOTROPHY; KIDNEY DISEASE; KIDNEY DYSPLASIA; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY PANCREAS TRANSPLANTATION; LABORATORY TEST; LEAN BODY WEIGHT; LETTER; MALE; MATURITY ONSET DIABETES MELLITUS OF THE YOUNG TYPE 5; MISSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CYSTIC HYPOTROPHY; PANCREAS DISEASE; PANCREAS FUNCTION; PANCREAS GRAFT REJECTION; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE DRUG DOSE; TREATMENT INDICATION; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ADULT; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; PANCREAS TRANSPLANTATION;

EID: 80054769487     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318230c0d7     Document Type: Letter

References (8)

1. Sampaio MS, Kuo HT, Bunnapradist S. Outcomes of simultaneous pancreas-kidney transplantation in type 2 diabetic recipients. Clin J Am Soc Nephrol 2011; 6: 1198.
2. Saudek F, Pruhova S, Boucek P, et al. Maturityonset diabetes of the young with end-stage nephropathy: A new indication for simultaneous pancreas and kidney transplantation? Transplantation 2004; 77: 1298.
3. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001; 345: 971.
4. Lindner TH, Njolstad PR, Horikawa Y, et al. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta. Hum Mol Genet 1999; 8: 2001.
5. Edghill EL, Bingham C, Slingerland AS, et al. Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: Support for a critical role of HNF-1 in human pancreatic development. Diabet Med 2006; 23: 1301.
6. Mayer C, Böttcher Y, Kovacs P, et al. Phenotype of a patient with a de novo mutation in the hepatocyte nuclear factor 1beta/maturityonset diabetes of the young type 5 gene. Metabolism 2008; 57: 416.
7. Bingham C, Ellard S, Allen L, et al. Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1 beta. Kidney Int 2000; 57: 898.
8. Bingham C, Ellard S, van't Hoff WG, et al. Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1beta gene mutation. Kidney Int 2003; 63: 1645.